STAT+: As the obesity drug market grows, digital health companies juggle patients and payers
STAT
AUGUST 21, 2023
But as digital health companies build out their weight loss businesses, capitalizing on the popularity of drugs like Wegovy and Ozempic, they’re courting a very different audience: payers and employers who have a vested interest in preventing quick scripts. The competition is growing quickly.
Let's personalize your content